|

Combination Agent 1 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 1/2: 2

Top Sponsors

  • Pfizer1
  • Avenzo Therapeutics, Inc.1

Indications

  • Lung Cancer2
  • Cancer2
  • Advanced/Metastatic Non-Small Cell Lung Cancer1
  • Epithelial Tumor1
  • Solid Tumor Cancer1

Gilbert, Arizona1 trial

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site

Phase 1/2

Orange City, Florida1 trial

A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

Mid Florida Hematology and Oncology Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.